The Brigham Presents at AUA 2022
Several Brigham doctors will present their latest research to international urologists at the American Urological Association’s (AUA) 2022 Annual Meeting, held May 13 – 16 in New Orleans.
Read More...Category: Urology
Specialty: Urology
Inquire About Lower Urinary Tract Symptoms in Patients With Endometriosis
In the first study of its kind, Iwona Gabriel, MD, PhD, and Vatche A. Minassian, MD, MPH, of the Urogynecology Group, and colleagues found women and adolescents with surgically confirmed endometriosis are at substantially greater risk than others of having multiple lower urinary tract symptoms.
Read More...Role of DNA Damage Response Genes in Prostate Cancer Similar for African Americans, European Americans
Adam S. Kibel, MD, and Anna Plym, PhD, of the Division of Urology, and colleagues conducted the most comprehensive study to date on the role of inherited DNA damage response (DDR) genes in aggressive prostate cancer. They report high carrier frequency of DDR gene alterations in lethal cases irrespective of ancestry.
Read More...Metabolic Syndrome and Its Treatment Affects Response to Androgen Deprivation Therapy in Metastatic Prostate Cancer
Adam S. Kibel, MD, and Jiun-Hung Geng, of the Brigham’s Division of Urology, and colleagues recently conducted the first study of how the combination of metabolic syndrome and its treatment affect response to androgen deprivation therapy in castration-sensitive prostate cancer.
Read More...Cardiac Risk Substantially Lower with Enzalutamide Than Abiraterone
Using the world’s largest pharmacovigilance database, Eugene B. Cone, MD, Quoc-Dien Trinh, MD, and colleagues determined the risk of cardiac adverse events is increased substantially with abiraterone and not at all with enzalutamide.
Read More...Urology Subspecialists Are Still Predominantly White, Male
Building a racially/ethnically representative urology workforce is becoming even more important. Elodi J. Dielubanza, MD, associate surgeon in the Division of Urology at Brigham and Women’s Hospital, and colleagues recently conducted the first study that describes demographic trends in urologic subspecialties.
Read More...Time-driven Activity-based Costing Informs Management of Acute Ureteral Stones
George E. Haleblian, MD, urologic surgeon in the Division of Urology at the Brigham, and colleagues applied TDABC to acute urolithiasis. They report wide variation in costs between care pathways, suggesting opportunities to trim inefficient or wasteful services.
Read More...Helping Women Navigate Changes in Their Pelvic Health
Elodi Dielubanza, MD, associate surgeon in the Brigham’s Division of Urology, is seeking to normalize female urinary tract and pelvic floor disorders. She helps patients with these disorders to restore their normal daily function through surgery, medications, physical therapy and behavior modification.
Read More...Taking Tumor Boards to the Next Level
While traditional tumor boards are common at most academic medical centers, Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) has taken its 10-year-old tumor board to the next level by integrating molecular pathology into their discussions.
Patient-Reported Outcome Measures Guiding Urology Care
The Division of Urology at Brigham and Women’s Hospital provides expert, individualized care for a range of urological conditions. Because many urological treatments have similar clinical outcomes, division surgeons are gathering data called patient-reported outcome measures (PROMs). They plan to use PROMs to better identify the nuances of treatment outcomes and determine how these outcomes affect quality of life for individual patients.